Loading…
Use of surveillance data in developing geographic dissemination strategies: A study of the diffusion of olanzapine to Michigan children insured by medicaid
Abstract Objective: The purpose of this study was to examinethe diffusion of olanzapine to urban and rural children insured by Medicaid in Michigan by identifying prescribing clusters through surveillance of claims records. Methods: Prescription claims records for all antipsychotic medications for 3...
Saved in:
Published in: | Clinical therapeutics 2007-02, Vol.29 (2), p.359-370 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c482t-b8c26ecfb26896d6987f5e57fa72585f80512f19a2a41e4134a1fbd5653541333 |
---|---|
cites | cdi_FETCH-LOGICAL-c482t-b8c26ecfb26896d6987f5e57fa72585f80512f19a2a41e4134a1fbd5653541333 |
container_end_page | 370 |
container_issue | 2 |
container_start_page | 359 |
container_title | Clinical therapeutics |
container_volume | 29 |
creator | Penfold, Robert B., PhD Kelleher, Kelly J., MD, MPH |
description | Abstract Objective: The purpose of this study was to examinethe diffusion of olanzapine to urban and rural children insured by Medicaid in Michigan by identifying prescribing clusters through surveillance of claims records. Methods: Prescription claims records for all antipsychotic medications for 3,567 children insured by Medicaid in Michigan from 1996 through 1998 were examined through the state Medicaid database. There were 29,069 pediatric prescriptions for antipsychotic medications; 2949 were for olanzapine (576 children, 510 providers). These data were linked to the Area Resource File, Provider Enrollment File, and Rural-Urban Commuting Area codes. Patient and provider locations were geocoded by ZIP code. Mixed logistic regression analysis was performed to determine the probability of a child's being prescribed olanzapine given certain community, patient, and provider characteristics. Spatial clusters were identified through the local Moron's L statistic and empirical Bayes standardized incidence rates. Results: Rural children were more likely than urbanchildren to be prescribed olanzapine (odds ratio [OR], 1.29; P < 0.001). There were significant differences by age and sex, with older children and girls more likely than younger children and boys to be prescribed olanzapine (OR, 1.30 and 1.37, respectively; both, P < 0.001). At the county level, the number of pediatricians per primary care physician reduced the likelihood of a child's being prescribed olanzapine (OR, 0.88; P = 0.039). The effect of the number of available mental health professionals was not significant. The global Moran's L statistic was U indicating modcrate clustering of the use of olanzapine. Conclusion: Graphic surveillance data may be usefulfor studying the delivery and use of health cue services. Further research is needed to determine how this method can be used strategically to facilitate or impede the diffusion of new medications. |
doi_str_mv | 10.1016/j.clinthera.2007.02.017 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70459920</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0149291807000586</els_id><sourcerecordid>2732794981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-b8c26ecfb26896d6987f5e57fa72585f80512f19a2a41e4134a1fbd5653541333</originalsourceid><addsrcrecordid>eNqNkt-KEzEUxgdR3Lr6ChoQvWtNMpNJ4oVQFv_Bihe64F1Ik5M2dTqpyUyhvoov6xlaLOyVV-GE3_ny5Xynql4wumCUtW-2C9fFfthAtgtOqVxQvqBMPqhmTEk9Z6z58bCaUdboOddMXVVPStlSSmst-OPqislGcsX1rPpzV4CkQMqYDxC7zvYOiLeDJbEnHg7QpX3s12QNaZ3tfhMd8bEU2MXeDjH1pAzZDrCOUN6SJVajP056aA3BEMYyQXiRUPq3RS0gQyJfotvEte0JHp3P0ONzaAE8WR3JDnx0Nvqn1aNguwLPzud1dffh_febT_Pbrx8_3yxv565RfJivlOMtuLDirdKtb7WSQYCQwUoulAiKCsYD05bbhkHD6saysPKiFbXAqq6vq9cn3X1Ov0Yog9nF4mAaBqSxGEkboTWnCL68B27TmHv0Zhituea8bjRS8kS5nErJEMw-x53NR4TMlJ7Zmn_pmSk9Q7nB9LDz-Vl_XOEQLn3nuBB4dQZscbYLGeOK5cIpzbVoJ6PLEwc4tkOEbIqLgNH6mMENxqf4H2be3dOYOAym-wlHKJefm4IN5tu0bNOuUYl7JlRb_wW6xtN0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1032922349</pqid></control><display><type>article</type><title>Use of surveillance data in developing geographic dissemination strategies: A study of the diffusion of olanzapine to Michigan children insured by medicaid</title><source>ScienceDirect Freedom Collection</source><creator>Penfold, Robert B., PhD ; Kelleher, Kelly J., MD, MPH</creator><creatorcontrib>Penfold, Robert B., PhD ; Kelleher, Kelly J., MD, MPH</creatorcontrib><description>Abstract Objective: The purpose of this study was to examinethe diffusion of olanzapine to urban and rural children insured by Medicaid in Michigan by identifying prescribing clusters through surveillance of claims records. Methods: Prescription claims records for all antipsychotic medications for 3,567 children insured by Medicaid in Michigan from 1996 through 1998 were examined through the state Medicaid database. There were 29,069 pediatric prescriptions for antipsychotic medications; 2949 were for olanzapine (576 children, 510 providers). These data were linked to the Area Resource File, Provider Enrollment File, and Rural-Urban Commuting Area codes. Patient and provider locations were geocoded by ZIP code. Mixed logistic regression analysis was performed to determine the probability of a child's being prescribed olanzapine given certain community, patient, and provider characteristics. Spatial clusters were identified through the local Moron's L statistic and empirical Bayes standardized incidence rates. Results: Rural children were more likely than urbanchildren to be prescribed olanzapine (odds ratio [OR], 1.29; P < 0.001). There were significant differences by age and sex, with older children and girls more likely than younger children and boys to be prescribed olanzapine (OR, 1.30 and 1.37, respectively; both, P < 0.001). At the county level, the number of pediatricians per primary care physician reduced the likelihood of a child's being prescribed olanzapine (OR, 0.88; P = 0.039). The effect of the number of available mental health professionals was not significant. The global Moran's L statistic was U indicating modcrate clustering of the use of olanzapine. Conclusion: Graphic surveillance data may be usefulfor studying the delivery and use of health cue services. Further research is needed to determine how this method can be used strategically to facilitate or impede the diffusion of new medications.</description><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/j.clinthera.2007.02.017</identifier><identifier>PMID: 17472829</identifier><language>eng</language><publisher>Belle Mead, NJ: EM Inc USA</publisher><subject>Adolescent ; Age Factors ; Antipsychotic Agents - supply & distribution ; Antipsychotic Agents - therapeutic use ; Benzodiazepines - supply & distribution ; Benzodiazepines - therapeutic use ; Biological and medical sciences ; Child ; Child, Preschool ; diffusion ; Ethnic Groups ; Family physicians ; Female ; geographic dissemination ; Geographic Information Systems ; geographic surveillance ; Health care ; Health Services Accessibility ; Health surveillance ; heterogeneity ; Humans ; Infant ; Information Dissemination ; Innovations ; Insurance Claim Review ; Internal Medicine ; Logistic Models ; Male ; Medicaid ; Medicaid - statistics & numerical data ; Medical Education ; Medical sciences ; Medical screening ; Medicare ; Mental disorders ; Mental health ; Michigan ; olanzapine ; Pediatrics ; Pharmacology. Drug treatments ; Physicians ; Population Surveillance ; Practice Patterns, Physicians' - statistics & numerical data ; prescribing practices ; Probability ; Professions ; Psychiatry ; Rural Health Services ; Rural Population ; Sex Factors ; Telemedicine ; Urban Health Services ; Urban Population</subject><ispartof>Clinical therapeutics, 2007-02, Vol.29 (2), p.359-370</ispartof><rights>Excerpta Medica, Inc.</rights><rights>2007 Excerpta Medica, Inc.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-b8c26ecfb26896d6987f5e57fa72585f80512f19a2a41e4134a1fbd5653541333</citedby><cites>FETCH-LOGICAL-c482t-b8c26ecfb26896d6987f5e57fa72585f80512f19a2a41e4134a1fbd5653541333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18929560$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17472829$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Penfold, Robert B., PhD</creatorcontrib><creatorcontrib>Kelleher, Kelly J., MD, MPH</creatorcontrib><title>Use of surveillance data in developing geographic dissemination strategies: A study of the diffusion of olanzapine to Michigan children insured by medicaid</title><title>Clinical therapeutics</title><addtitle>Clin Ther</addtitle><description>Abstract Objective: The purpose of this study was to examinethe diffusion of olanzapine to urban and rural children insured by Medicaid in Michigan by identifying prescribing clusters through surveillance of claims records. Methods: Prescription claims records for all antipsychotic medications for 3,567 children insured by Medicaid in Michigan from 1996 through 1998 were examined through the state Medicaid database. There were 29,069 pediatric prescriptions for antipsychotic medications; 2949 were for olanzapine (576 children, 510 providers). These data were linked to the Area Resource File, Provider Enrollment File, and Rural-Urban Commuting Area codes. Patient and provider locations were geocoded by ZIP code. Mixed logistic regression analysis was performed to determine the probability of a child's being prescribed olanzapine given certain community, patient, and provider characteristics. Spatial clusters were identified through the local Moron's L statistic and empirical Bayes standardized incidence rates. Results: Rural children were more likely than urbanchildren to be prescribed olanzapine (odds ratio [OR], 1.29; P < 0.001). There were significant differences by age and sex, with older children and girls more likely than younger children and boys to be prescribed olanzapine (OR, 1.30 and 1.37, respectively; both, P < 0.001). At the county level, the number of pediatricians per primary care physician reduced the likelihood of a child's being prescribed olanzapine (OR, 0.88; P = 0.039). The effect of the number of available mental health professionals was not significant. The global Moran's L statistic was U indicating modcrate clustering of the use of olanzapine. Conclusion: Graphic surveillance data may be usefulfor studying the delivery and use of health cue services. Further research is needed to determine how this method can be used strategically to facilitate or impede the diffusion of new medications.</description><subject>Adolescent</subject><subject>Age Factors</subject><subject>Antipsychotic Agents - supply & distribution</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Benzodiazepines - supply & distribution</subject><subject>Benzodiazepines - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>diffusion</subject><subject>Ethnic Groups</subject><subject>Family physicians</subject><subject>Female</subject><subject>geographic dissemination</subject><subject>Geographic Information Systems</subject><subject>geographic surveillance</subject><subject>Health care</subject><subject>Health Services Accessibility</subject><subject>Health surveillance</subject><subject>heterogeneity</subject><subject>Humans</subject><subject>Infant</subject><subject>Information Dissemination</subject><subject>Innovations</subject><subject>Insurance Claim Review</subject><subject>Internal Medicine</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medicaid</subject><subject>Medicaid - statistics & numerical data</subject><subject>Medical Education</subject><subject>Medical sciences</subject><subject>Medical screening</subject><subject>Medicare</subject><subject>Mental disorders</subject><subject>Mental health</subject><subject>Michigan</subject><subject>olanzapine</subject><subject>Pediatrics</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicians</subject><subject>Population Surveillance</subject><subject>Practice Patterns, Physicians' - statistics & numerical data</subject><subject>prescribing practices</subject><subject>Probability</subject><subject>Professions</subject><subject>Psychiatry</subject><subject>Rural Health Services</subject><subject>Rural Population</subject><subject>Sex Factors</subject><subject>Telemedicine</subject><subject>Urban Health Services</subject><subject>Urban Population</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNkt-KEzEUxgdR3Lr6ChoQvWtNMpNJ4oVQFv_Bihe64F1Ik5M2dTqpyUyhvoov6xlaLOyVV-GE3_ny5Xynql4wumCUtW-2C9fFfthAtgtOqVxQvqBMPqhmTEk9Z6z58bCaUdboOddMXVVPStlSSmst-OPqislGcsX1rPpzV4CkQMqYDxC7zvYOiLeDJbEnHg7QpX3s12QNaZ3tfhMd8bEU2MXeDjH1pAzZDrCOUN6SJVajP056aA3BEMYyQXiRUPq3RS0gQyJfotvEte0JHp3P0ONzaAE8WR3JDnx0Nvqn1aNguwLPzud1dffh_febT_Pbrx8_3yxv565RfJivlOMtuLDirdKtb7WSQYCQwUoulAiKCsYD05bbhkHD6saysPKiFbXAqq6vq9cn3X1Ov0Yog9nF4mAaBqSxGEkboTWnCL68B27TmHv0Zhituea8bjRS8kS5nErJEMw-x53NR4TMlJ7Zmn_pmSk9Q7nB9LDz-Vl_XOEQLn3nuBB4dQZscbYLGeOK5cIpzbVoJ6PLEwc4tkOEbIqLgNH6mMENxqf4H2be3dOYOAym-wlHKJefm4IN5tu0bNOuUYl7JlRb_wW6xtN0</recordid><startdate>20070201</startdate><enddate>20070201</enddate><creator>Penfold, Robert B., PhD</creator><creator>Kelleher, Kelly J., MD, MPH</creator><general>EM Inc USA</general><general>Excerpta Medica</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20070201</creationdate><title>Use of surveillance data in developing geographic dissemination strategies: A study of the diffusion of olanzapine to Michigan children insured by medicaid</title><author>Penfold, Robert B., PhD ; Kelleher, Kelly J., MD, MPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-b8c26ecfb26896d6987f5e57fa72585f80512f19a2a41e4134a1fbd5653541333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Age Factors</topic><topic>Antipsychotic Agents - supply & distribution</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Benzodiazepines - supply & distribution</topic><topic>Benzodiazepines - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>diffusion</topic><topic>Ethnic Groups</topic><topic>Family physicians</topic><topic>Female</topic><topic>geographic dissemination</topic><topic>Geographic Information Systems</topic><topic>geographic surveillance</topic><topic>Health care</topic><topic>Health Services Accessibility</topic><topic>Health surveillance</topic><topic>heterogeneity</topic><topic>Humans</topic><topic>Infant</topic><topic>Information Dissemination</topic><topic>Innovations</topic><topic>Insurance Claim Review</topic><topic>Internal Medicine</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medicaid</topic><topic>Medicaid - statistics & numerical data</topic><topic>Medical Education</topic><topic>Medical sciences</topic><topic>Medical screening</topic><topic>Medicare</topic><topic>Mental disorders</topic><topic>Mental health</topic><topic>Michigan</topic><topic>olanzapine</topic><topic>Pediatrics</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicians</topic><topic>Population Surveillance</topic><topic>Practice Patterns, Physicians' - statistics & numerical data</topic><topic>prescribing practices</topic><topic>Probability</topic><topic>Professions</topic><topic>Psychiatry</topic><topic>Rural Health Services</topic><topic>Rural Population</topic><topic>Sex Factors</topic><topic>Telemedicine</topic><topic>Urban Health Services</topic><topic>Urban Population</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Penfold, Robert B., PhD</creatorcontrib><creatorcontrib>Kelleher, Kelly J., MD, MPH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Penfold, Robert B., PhD</au><au>Kelleher, Kelly J., MD, MPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of surveillance data in developing geographic dissemination strategies: A study of the diffusion of olanzapine to Michigan children insured by medicaid</atitle><jtitle>Clinical therapeutics</jtitle><addtitle>Clin Ther</addtitle><date>2007-02-01</date><risdate>2007</risdate><volume>29</volume><issue>2</issue><spage>359</spage><epage>370</epage><pages>359-370</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><abstract>Abstract Objective: The purpose of this study was to examinethe diffusion of olanzapine to urban and rural children insured by Medicaid in Michigan by identifying prescribing clusters through surveillance of claims records. Methods: Prescription claims records for all antipsychotic medications for 3,567 children insured by Medicaid in Michigan from 1996 through 1998 were examined through the state Medicaid database. There were 29,069 pediatric prescriptions for antipsychotic medications; 2949 were for olanzapine (576 children, 510 providers). These data were linked to the Area Resource File, Provider Enrollment File, and Rural-Urban Commuting Area codes. Patient and provider locations were geocoded by ZIP code. Mixed logistic regression analysis was performed to determine the probability of a child's being prescribed olanzapine given certain community, patient, and provider characteristics. Spatial clusters were identified through the local Moron's L statistic and empirical Bayes standardized incidence rates. Results: Rural children were more likely than urbanchildren to be prescribed olanzapine (odds ratio [OR], 1.29; P < 0.001). There were significant differences by age and sex, with older children and girls more likely than younger children and boys to be prescribed olanzapine (OR, 1.30 and 1.37, respectively; both, P < 0.001). At the county level, the number of pediatricians per primary care physician reduced the likelihood of a child's being prescribed olanzapine (OR, 0.88; P = 0.039). The effect of the number of available mental health professionals was not significant. The global Moran's L statistic was U indicating modcrate clustering of the use of olanzapine. Conclusion: Graphic surveillance data may be usefulfor studying the delivery and use of health cue services. Further research is needed to determine how this method can be used strategically to facilitate or impede the diffusion of new medications.</abstract><cop>Belle Mead, NJ</cop><pub>EM Inc USA</pub><pmid>17472829</pmid><doi>10.1016/j.clinthera.2007.02.017</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-2918 |
ispartof | Clinical therapeutics, 2007-02, Vol.29 (2), p.359-370 |
issn | 0149-2918 1879-114X |
language | eng |
recordid | cdi_proquest_miscellaneous_70459920 |
source | ScienceDirect Freedom Collection |
subjects | Adolescent Age Factors Antipsychotic Agents - supply & distribution Antipsychotic Agents - therapeutic use Benzodiazepines - supply & distribution Benzodiazepines - therapeutic use Biological and medical sciences Child Child, Preschool diffusion Ethnic Groups Family physicians Female geographic dissemination Geographic Information Systems geographic surveillance Health care Health Services Accessibility Health surveillance heterogeneity Humans Infant Information Dissemination Innovations Insurance Claim Review Internal Medicine Logistic Models Male Medicaid Medicaid - statistics & numerical data Medical Education Medical sciences Medical screening Medicare Mental disorders Mental health Michigan olanzapine Pediatrics Pharmacology. Drug treatments Physicians Population Surveillance Practice Patterns, Physicians' - statistics & numerical data prescribing practices Probability Professions Psychiatry Rural Health Services Rural Population Sex Factors Telemedicine Urban Health Services Urban Population |
title | Use of surveillance data in developing geographic dissemination strategies: A study of the diffusion of olanzapine to Michigan children insured by medicaid |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T23%3A10%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20surveillance%20data%20in%20developing%20geographic%20dissemination%20strategies:%20A%20study%20of%20the%20diffusion%20of%20olanzapine%20to%20Michigan%20children%20insured%20by%20medicaid&rft.jtitle=Clinical%20therapeutics&rft.au=Penfold,%20Robert%20B.,%20PhD&rft.date=2007-02-01&rft.volume=29&rft.issue=2&rft.spage=359&rft.epage=370&rft.pages=359-370&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/j.clinthera.2007.02.017&rft_dat=%3Cproquest_cross%3E2732794981%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-b8c26ecfb26896d6987f5e57fa72585f80512f19a2a41e4134a1fbd5653541333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1032922349&rft_id=info:pmid/17472829&rfr_iscdi=true |